Neoadjuvant Nivolumab Appears Effective for Resectable, dMMR Endometrial Cancer Oncology Nurse Advisor
Demonstrate a successful laparoscopic removal of endometriosis from within the inguinal canal via a step-by-step video explanation, underscore the importance of pre-operative MRI imaging, and provide education on anatomy and …
Artificial intelligence (AI) may have the potential to improve existing diagnostic challenges in endometriosis imaging. To better direct future research, this descriptive review summarizes the general landscape of AI applications …
Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer OncLive
How does adenomyosis affect live birth rates (LBRs) in women undergoing ART compared to a matched control population?
This study evaluated the effectiveness of quinagolide vaginal ring on reducing total lesion size in endometrioma, deep infiltrating endometriosis (DIE), and adenomyosis, as assessed using high-resolution MRI and imaging biomarkers.
Dr Eskander on the Potential Clinical Benefit of Nivolumab in dMMR Endometrial Cancer OncLive
Endometriosis is a chronic systemic disease characterized by the presence of endometrium-like glands and/or stroma outside the uterus, usually with an associated inflammatory process. It affects around 5-10% of women …
Endometriosis has been hypothesized to increase the risk of preeclampsia (PE) and eclampsia, although the exact mechanism of this relationship is not clear. This study aimed to further explore the …
Endometriosis is caused by the migration of endometrial cells to locations outside the uterine lining. Despite the increasing prevalence of endometriosis, there has been limited research on genetic effects, and …